Cohort Profile: NICHD international site development initiative (nisdi): A prospective, observational study of HIV-exposed and HIV-infected children at clinical sites in Latin American and caribbean countries
Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1
Gortmaker SL, Hughes M, Cervia J et al. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Engl J Med 2001;345 1522-28.
Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites
Read JS, Cahn P, Losso M et al. Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites. Obstet Gynecol 2007;109:1358-67.
Perinatal HIV Guidelines Working Group. Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. November 2, 2007, pp. 59-60. Available at http://aidsinfo.nih.gov/ContentFiles/PerinatalGL.pdf (Accessed February 22, 2008).
Perinatal HIV Guidelines Working Group. Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. November 2, 2007, pp. 59-60. Available at http://aidsinfo.nih.gov/ContentFiles/PerinatalGL.pdf (Accessed February 22, 2008).
5
33748049770
Mitochondrial dysfunction: Prevention of HIV-1 mother-to-infant transmission outweighs fear
Spector SA, Saitoh A. Mitochondrial dysfunction: Prevention of HIV-1 mother-to-infant transmission outweighs fear. AIDS 2006;20 1777-78.
Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group
Connor EM, Sperling RS, Gelber R et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994;331:1173-80.
Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/ 076 Teams
Culnane M, Fowler M, Lee SS et al. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/ 076 Teams. JAMA 1999;281:151-57.
Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme
McGowan CC, Cahn P, Gotuzzo E et al. Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme. Int J Epidemiol 2007;36 969-76.